Sen. Johnson’s Health Improves
Sen. Tim Johnson, D-S.D., whose sudden illness last month briefly threatened the Democrats' control of the Senate, has been given a medical status upgrade from critical to fair. We wish him well.
Sen. Tim Johnson, D-S.D., whose sudden illness last month briefly threatened the Democrats’ control of the Senate, had been given a medical status upgrade from critical to fair. We wish him well.
Rooted in Truth.BBC:
Mr Johnson’s spokeswoman, Julianne Fisher, told news agencies that the senator’s condition “had been upgraded from critical to fair”.
“The senator continues to make progress,” she said, adding: “The next step would be rehabilitation and we hope that would happen within the week.”
Mr Johnson was admitted to George Washington University hospital on 13 December after experiencing what his office initially said was a possible stroke.
According to the hospital, a health status of “fair” means that vital signs like blood pressure and temperature are stable and within normal limits.
Independent by Design.
Your support helps ensure that rigorous reporting, thoughtful analysis, and investigative journalism remain accessible to everyone.
Support independent journalism.
Ear to the Ground
Democrats in tight races have spoken out against trans rights, but adopting Republican talking points may haunt them in November.
TD Column
The centrist crusade against a rising left is just beginning. It’s also hypocritical, out of touch and doomed to fail.
TD Column
For the first time since the tea party wave of 2010, multiple Midwest trifectas are in play.
TD Column
In Michigan’s intra-party slugfest, a majority of Democratic voters are refusing orders to follow the usual centrist script.
Politics
As billionaires further enrich themselves while dismantling democracy, Americans are warned against voting for “godless communism.”
Economic Justice
Democrats must finally take on the class war that’s being waged by the nation’s oligarchy against most Americans.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.